Search

everythinglearnresearchcommunity

for

Search:↓

The most common skin diseases found were contact dermatitis, scabies, fungal infections, urticaria, and acne, highlighting the need for better public health policies and awareness.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

The document lists various dermatology topics, treatments, and diagnostic methods.

A woman's hair grew back within 3 months after temporary hair loss from improper head positioning during shoulder surgery.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Henna mixed with PPD can cause skin reactions, scarring, and a specific type of baldness, and needs more research to understand these effects.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Surgical therapies for vitiligo vary in effectiveness, with combination therapy and medical tattooing recommended for better results.

Hair loss may increase heart disease risk.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.

Tazarotene gel may be more effective for acne than adapalene gel.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Topical minoxidil can cause unwanted hair growth and eye issues, especially in infants, so better education and guidelines are needed.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

JAK inhibitors offer new hope for treating severe alopecia areata.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

New nanocarriers improve drug delivery for disease treatment.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.